Literature DB >> 34432416

Tyrosine-Based Cross-Linking of Peptide Antigens to Generate Nanoclusters with Enhanced Immunogenicity: Demonstration Using the Conserved M2e Peptide of Influenza A.

Logan R Wilks1, Gaurav Joshi1, Megan R Grisham1, Harvinder Singh Gill1.   

Abstract

A method of creating nanoclusters (NCs) from soluble peptide molecules is described utilizing an approach based on a tyrosine-tyrosine cross-linking reaction. A reactive tag comprising histidine and tyrosine residues was introduced at the termini of the peptide molecules. The cross-linking reaction led to the creation of dityrosine bonds within the tag, which allowed for the generation of peptide NCs. We show that it is essential for the reactive tag to be present at both the "N" and "C" termini of the peptide for cluster formation to occur. Additionally, the cross-linking reaction was systematically characterized to show the importance of reaction conditions on final cluster diameter, allowing us to generate NCs of various sizes. To demonstrate the immunogenic potential of the peptide clusters, we chose to study the conserved influenza peptide, M2e, as the antigen. M2e NCs were formulated using the cross-linking reaction. We show the ability of the clusters to generate protective immunity in a dose, size, and frequency dependent manner against a lethal influenza A challenge in BALB/c mice. Taken together, the data presented suggest this new cluster formation technique can generate highly immunogenic peptide NCs in a simple and controllable manner.

Entities:  

Keywords:  M2e; antigen; influenza; peptide; tyrosine cross-linking; vaccine

Mesh:

Substances:

Year:  2021        PMID: 34432416      PMCID: PMC8521439          DOI: 10.1021/acsinfecdis.1c00219

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.578


  63 in total

1.  Optimization of the preparation process for human serum albumin (HSA) nanoparticles.

Authors:  K Langer; S Balthasar; V Vogel; N Dinauer; H von Briesen; D Schubert
Journal:  Int J Pharm       Date:  2003-05-12       Impact factor: 5.875

2.  Influence of cadmium, nickel, and chromium on primary immunity in mice.

Authors:  J A Graham; F J Miller; M J Daniels; E A Payne; D E Gardner
Journal:  Environ Res       Date:  1978-07       Impact factor: 6.498

3.  Synthesis, Characterization, and Catalytic Activities of A Nickel(II) Monoamido-Tetradentate Complex: Evidence For NiIII -Oxo and NiIV -Oxo Species.

Authors:  Kwon Hee Bok; Myoung Mi Lee; Ga Rim You; Hye Mi Ahn; Ka Young Ryu; Sung-Jin Kim; Youngmee Kim; Cheal Kim
Journal:  Chemistry       Date:  2017-02-03       Impact factor: 5.236

4.  Cross-Linked Peptide Nanoclusters for Delivery of Oncofetal Antigen as a Cancer Vaccine.

Authors:  Alexandra N Tsoras; Julie A Champion
Journal:  Bioconjug Chem       Date:  2018-02-13       Impact factor: 4.774

Review 5.  CpG DNA as a vaccine adjuvant.

Authors:  Christian Bode; Gan Zhao; Folkert Steinhagen; Takeshi Kinjo; Dennis M Klinman
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

6.  Determining protein-protein interactions by oxidative cross-linking of a glycine-glycine-histidine fusion protein.

Authors:  K C Brown; Z Yu; A L Burlingame; C S Craik
Journal:  Biochemistry       Date:  1998-03-31       Impact factor: 3.162

7.  Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.

Authors:  Lei Yang; Fude Cui; Dongmei Cun; Anjin Tao; Kai Shi; Wenhui Lin
Journal:  Int J Pharm       Date:  2007-03-25       Impact factor: 5.875

8.  A critical role for tyrosine residues in His6Ni-mediated protein cross-linking.

Authors:  D A Fancy; T Kodadek
Journal:  Biochem Biophys Res Commun       Date:  1998-06-18       Impact factor: 3.575

Review 9.  Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines.

Authors:  Yu-Na Lee; Min-Chul Kim; Young-Tae Lee; Yu-Jin Kim; Sang-Moo Kang
Journal:  Immune Netw       Date:  2015-10-26       Impact factor: 6.303

10.  Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag'.

Authors:  Jing Jin; Kathryn A Hjerrild; Sarah E Silk; Rebecca E Brown; Geneviève M Labbé; Jennifer M Marshall; Katherine E Wright; Sandra Bezemer; Stine B Clemmensen; Sumi Biswas; Yuanyuan Li; Aadil El-Turabi; Alexander D Douglas; Pim Hermans; Frank J Detmers; Willem A de Jongh; Matthew K Higgins; Rebecca Ashfield; Simon J Draper
Journal:  Int J Parasitol       Date:  2017-01-30       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.